Clinical Trials Directory

Trials / Sponsors / Aptevo Therapeutics

Aptevo Therapeutics

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
WithdrawnStudy of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML
AML
Phase 12025-01-01
RecruitingAPVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Acute Myeloid Leukemia (AML)
Phase 12024-10-01
UnknownALG.APV-527 First-in-human Study
Solid Tumor
Phase 1 / Phase 22022-12-23
TerminatedStudy to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis
Psoriasis, Ulcerative Colitis
Phase 12019-03-18
CompletedStudy of ES414 in Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer
Phase 12015-01-01
TerminatedPhase 1b Safety and Efficacy Study of TRU-016
Chronic Lymphocytic Leukemia, Peripheral T-cell Lymphoma
Phase 12012-09-01
CompletedA Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma
B-cell Small Lymphocytic Lymphoma Recurrent
Phase 12011-05-01
CompletedSafety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukem
Chronic Lymphocytic Leukemia (CLL)
Phase 1 / Phase 22010-09-01
CompletedPhase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lympho
Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL)
Phase 12008-01-01